GT-multi-siRNA

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameGT-multi-siRNA
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionHuman telomerase (hTERT)-directed cytolytic effects
TargetsTelomerase reverse transcriptaseGolgi membrane protein 1
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Sci-Tech University
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Sci-Tech University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A